Plantier; Jean-Luc

Patent Applications and Registrations

Patent applications and USPTO patent grants for Plantier; Jean-Luc.The latest application filed is for "combination of factor vii and an anti-factor ix/x bispecific antibody".

Company Profile

1.6.14

Plantier; Jean-Luc - Croix FR
Plantier; Jean-Luc - Gringy FR
Plantier; Jean Luc - Grigny FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Of Factor Vii And An Anti-factor Ix/x Bispecific Antibody App 20220152197 - Plantier; Jean-Luc	2022-05-19
Combination Of Factor Vii And An Anti-factor Ix/x Bispecific Antibody App 20210275668 - Plantier; Jean-Luc	2021-09-09
Factor X Variants App 20190338269 - CHTOUROU; Abdessatar Sami ; et al.	2019-11-07
Factor X mutants Grant 10,364,424 - Plantier	2019-07-30
Injectable Composition Of Factor Vii And Fillers App 20180169297 - Chtourou; Abdessatar ; et al.	2018-06-21
Biological Glue And Use Thereof As A Medicament App 20170296694 - CHTOUROU; Abdessatar Sami ; et al.	2017-10-19
Use of antidotes to coagulation inhibitors indicated in the prevention or treatment of thromboembolic pathologies Grant 9,700,603 - Plantier , et al. July 11, 2	2017-07-11
Gla-domainless Factor X App 20160177286 - Thomas; Aline ; et al.	2016-06-23
Factor X Mutants App 20160145598 - PLANTIER; Jean-Luc	2016-05-26
Use Of Antidotes To Coagulation Inhibitors Indicated In The Prevention Or Treatment Of Thromboembolic Pathologies App 20150343033 - PLANTIER; Jean-Luc ; et al.	2015-12-03
VIII factors for the treatment of type A hemophilia Grant 8,623,824 - Saboulard , et al. January 7, 2	2014-01-07
Modified Coagulation Factor VIII With Enhanced Stability and Its Derivatives App 20110124565 - Hauser; Hans-Peter ; et al.	2011-05-26
Novel VIII Factors for the Treatment of Type A Hemophilia App 20100311659 - Saboulard; Didier ; et al.	2010-12-09
Modified Cdna for High Expression Levels of Factor VIII and Its Derivatives App 20080312143 - Hauser; Hans-Peter ; et al.	2008-12-18
Modified factor VIII cDNA Grant 6,800,461 - Negrier , et al. October 5, 2	2004-10-05
Modified factor VIII cDNA and its use for the production of factor VIII Grant 6,780,614 - Negrier , et al. August 24, 2	2004-08-24
Modified cDNA for high expression levels of factor VIII and its derivatives App 20030083257 - Negrier, Claude ; et al.	2003-05-01
Modified factor VIII cDNA and its use for the production of factor VIII App 20020182684 - Negrier, Claude ; et al.	2002-12-05
Modified factor VIII cDNA App 20020165177 - Negrier, Claude ; et al.	2002-11-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.